Dr. Kaur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York St
New Haven, CT 06510Phone+1 203-688-4242
Education & Training
All India Institute of Medical SciencesClass of 2016
Certifications & Licensure
CT State Medical License 2024 - 2025
MA State Medical License 2022 - 2025- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Clinical Trials
- BXCL501 for Agitation in Schizophrenia Start of enrollment: 2020 Mar 09
Publications & Presentations
PubMed
- 65 citationsAssociation of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.Harsimar B. Kaur, Liana B. Guedes, Jiayun Lu, Laneisha Maldonado, Logan Reitz
Modern Pathology. 2018-05-30 - 64 citationsHomologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer.Tamara L. Lotan, Harsimar B. Kaur, Daniela C. Salles, Sanjana Murali, Edward M. Schaeffer
Modern Pathology. 2021-01-18 - 21 citationsNeuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.Harsimar B. Kaur, Iryna Samarska, Jiayun Lu, Farzana A. Faisal, Benjamin L. Maughan
The Prostate. 2020-09-01
Journal Articles
- Original Contribution TP53 Missense Mutation Is Associated with Increased Tumor-Infiltrating T-cells in Primary Prostate Cancer☆Tamara L Lotan, Mario Eisenberger, Harsimar B Kaur, Scott A Tomlins, Edward M Schaeffer, ScienceDirect
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
